Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ARSENIC TRIOXIDE for Neoplasm malignant: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 6 adverse event reports in the FDA FAERS database where ARSENIC TRIOXIDE was used for Neoplasm malignant.

Most Reported Side Effects for ARSENIC TRIOXIDE

Side Effect Reports % Deaths Hosp.
Differentiation syndrome 180 15.3% 14 87
Electrocardiogram qt prolonged 148 12.6% 5 42
Off label use 128 10.9% 8 61
Acute promyelocytic leukaemia differentiation syndrome 51 4.3% 18 16
Hyperleukocytosis 49 4.2% 1 26
Drug ineffective 45 3.8% 21 15
Acute kidney injury 42 3.6% 9 26
Leukaemia recurrent 41 3.5% 16 1
Hypokalaemia 40 3.4% 1 21
Idiopathic intracranial hypertension 38 3.2% 3 2
Pericarditis 34 2.9% 0 21
Neutropenia 33 2.8% 6 4
White blood cell count increased 32 2.7% 0 1
Diarrhoea 30 2.6% 0 20
Anaemia 28 2.4% 2 3

Other Indications for ARSENIC TRIOXIDE

Acute promyelocytic leukaemia (763) Acute myeloid leukaemia (111) Product used for unknown indication (89) Acute leukaemia (18) Colorectal cancer metastatic (15) Leukaemia recurrent (13) Plasma cell myeloma (13) Ewing's sarcoma (12) Neuroblastoma (10) Adult t-cell lymphoma/leukaemia (7)

Other Drugs Used for Neoplasm malignant

PALBOCICLIB (1,996) CAPECITABINE (1,493) PEMBROLIZUMAB (1,135) PACLITAXEL (984) CARBOPLATIN (977) NIVOLUMAB (947) OXALIPLATIN (823) PAZOPANIB (716) CYCLOPHOSPHAMIDE (685) FLUOROURACIL (676)

Related Pages

ARSENIC TRIOXIDE Full Profile All Neoplasm malignant Drugs ARSENIC TRIOXIDE Demographics ARSENIC TRIOXIDE Timeline